Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6208042rdf:typepubmed:Citationlld:pubmed
pubmed-article:6208042lifeskim:mentionsumls-concept:C0034798lld:lifeskim
pubmed-article:6208042lifeskim:mentionsumls-concept:C0038585lld:lifeskim
pubmed-article:6208042lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:6208042lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:6208042pubmed:issue1-2lld:pubmed
pubmed-article:6208042pubmed:dateCreated1984-12-20lld:pubmed
pubmed-article:6208042pubmed:abstractTextRepeated treatment with, but not single administration of drugs which impair dopaminergic transmission produced a consistent reduction in substance P immunoreactivity in the rat substantia nigra. This effect appears to be related to the D-2 dopamine receptor function as the blockade of this receptor subtype by selective antagonists produced effects qualitatively similar to those produced by drugs lacking selectivity for different subclasses of dopamine receptors.lld:pubmed
pubmed-article:6208042pubmed:languageenglld:pubmed
pubmed-article:6208042pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6208042pubmed:citationSubsetIMlld:pubmed
pubmed-article:6208042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6208042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6208042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6208042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6208042pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6208042pubmed:statusMEDLINElld:pubmed
pubmed-article:6208042pubmed:monthOctlld:pubmed
pubmed-article:6208042pubmed:issn0014-2999lld:pubmed
pubmed-article:6208042pubmed:authorpubmed-author:ZivkovicBBlld:pubmed
pubmed-article:6208042pubmed:authorpubmed-author:BartholiniGGlld:pubmed
pubmed-article:6208042pubmed:authorpubmed-author:OblinAAlld:pubmed
pubmed-article:6208042pubmed:issnTypePrintlld:pubmed
pubmed-article:6208042pubmed:day1lld:pubmed
pubmed-article:6208042pubmed:volume105lld:pubmed
pubmed-article:6208042pubmed:ownerNLMlld:pubmed
pubmed-article:6208042pubmed:authorsCompleteYlld:pubmed
pubmed-article:6208042pubmed:pagination175-7lld:pubmed
pubmed-article:6208042pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:meshHeadingpubmed-meshheading:6208042-...lld:pubmed
pubmed-article:6208042pubmed:year1984lld:pubmed
pubmed-article:6208042pubmed:articleTitleInvolvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P.lld:pubmed
pubmed-article:6208042pubmed:publicationTypeJournal Articlelld:pubmed